A community pharmacy asthma MUR project in Hampshire and the isle of Wight

摘要

Aim To optimise the outcomes of medicines use reviews (MURs) DesignA prospective analysis of community pharmacies' asthma MUR interventions and service evaluation through questionnaire feedback. Subjects and setting 47 community pharmacies in the Hampshire and Isle of Wight Local Pharmaceutical Committee area. Outcome measures Improved access to support, particularly for patients who tended not to attend asthma review clinics with their GP or practice nurse. Improved patient adherence to prescribed treatment resulting from a concordant consultation. Demonstrable benefits of the targeted MUR service. Results 965 patients received an asthma MUR from 46 pharmacies, which each averaged 21 asthma MURs (range 1—67) between July and December 2007.63 per cent of patients were primarily adherent to their asthma medication. Difficulty using the inhaler was the most common secondary adherence issue in primary adherent (41%, 123) and non-adherent (44% 158) patients, followed by belief in their medicines. 30 per cent of atients who received an MUR had not seen their GP or practice nurse in the past 12. months. Pharmacists made a total of 1,787 interventions (average 1.8 per MUR consultation) with most being divided between patient education (49%) and device check and demonstration (41%). 230 patients provided requested feedback (24%). 33 per cent of patients who responded to the feedback questionnaire used the MUR service to gain more confidence about their asthma treatment ancf 19 per cent were seeking specific advice from the consultation. Conclusions Community pharmacists have an important role to play in the management of patients with asthma through a targeted MUR service.